Fil LTD Revolution Medicines, Inc. Transaction History

Fil LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$37.21 - $54.43 $6,288 - $9,198	-169 Closed	0 $0
Q4 2020 Feb 08, 2021	SELL	$30.19 - $45.49 $3.16 Million - $4.76 Million	-104,604 Reduced 99.84%	169 $7,000
Q2 2020 Aug 13, 2020	SELL	$19.65 - $39.34 $1.78 Million - $3.57 Million	-90,674 Reduced 46.39%	104,773 $3.31 Million
Q1 2020 May 14, 2020	BUY	$20.0 - $34.08 $3.91 Million - $6.66 Million	195,447 New	195,447 $4.28 Million

280

162M

260K

620K

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $3.7B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

Stay updated on Fil LTD with notifications on news.